MIRM
Mirum Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$6.01B
P/E Ratio
—
EPS
$-13.60
Beta
0.52
52W High
$114.99
52W Low
$43.30
50-Day MA
$96.57
200-Day MA
$83.53
Dividend Yield
—
Profit Margin
-140.20%
Forward P/E
2000.00
PEG Ratio
—
About Mirum Pharmaceuticals Inc
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, is focused on the development and commercialization of an advanced line of novel therapies for debilitating liver diseases. The company is headquartered in Foster City, California.
Fundamentals
| Revenue (TTM) | $569.61M |
| Gross Profit (TTM) | $463.58M |
| EBITDA | $-50.05M |
| Operating Margin | -39.50% |
| Return on Equity | -335.80% |
| Return on Assets | -5.94% |
| Revenue/Share (TTM) | $10.81 |
| Book Value | $3.98 |
| Price-to-Book | 24.80 |
| Price-to-Sales (TTM) | 10.56 |
| EV/Revenue | 10.45 |
| EV/EBITDA | 341.15 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 43.30% |
| Shares Outstanding | $60.98M |
| Float | $52.48M |
| % Insiders | 1.35% |
| % Institutions | 115.10% |
Historical Volatility
HV 10-Day
63.39%
HV 20-Day
65.51%
HV 30-Day
55.36%
HV 60-Day
49.84%
HV Rank
86.9%
Volatility is currently expanding
Analyst Ratings
Consensus ($144.15 target)
3
Strong Buy8
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026